News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
405,852 Results
Type
Article (32624)
Company Profile (64)
Press Release (373153)
Multimedia
Podcasts (57)
Webinars (5)
Section
Business (113110)
Career Advice (1332)
Deals (24106)
Drug Delivery (97)
Drug Development (59933)
Employer Resources (104)
FDA (10095)
Job Trends (9114)
News (212286)
Policy (25682)
Tag
Academia (1845)
Accelerated approval (14)
Adcomms (25)
Allergies (85)
Alliances (42406)
ALS (86)
Alzheimer's disease (1221)
Antibody-drug conjugate (ADC) (136)
Approvals (10096)
Artificial intelligence (230)
Autoimmune disease (26)
Automation (12)
Bankruptcy (238)
Best Places to Work (7694)
BIOSECURE Act (16)
Biosimilars (104)
Biotechnology (44)
Bladder cancer (77)
Brain cancer (40)
Breast cancer (286)
Cancer (2447)
Cardiovascular disease (206)
Career advice (1126)
Career pathing (21)
CAR-T (148)
CDC (42)
Cell therapy (391)
Cervical cancer (20)
Clinical research (49388)
Collaboration (969)
Company closure (3)
Compensation (708)
Complete response letters (34)
COVID-19 (2551)
CRISPR (51)
C-suite (227)
Cystic fibrosis (70)
Data (2615)
Decentralized trials (1)
Denatured (9)
Depression (64)
Diabetes (307)
Diagnostics (3635)
Digital health (16)
Diversity (5)
Diversity, equity & inclusion (34)
Drug discovery (120)
Drug pricing (131)
Drug shortages (31)
Duchenne muscular dystrophy (145)
Earnings (41867)
Editorial (44)
Employer branding (13)
Employer resources (95)
Events (47145)
Executive appointments (395)
FDA (11623)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (660)
Gene editing (105)
Generative AI (18)
Gene therapy (329)
GLP-1 (809)
Government (4274)
Grass and pollen (5)
Guidances (260)
Healthcare (11431)
HIV (40)
Huntington's disease (25)
IgA nephropathy (41)
Immunology and inflammation (130)
Immuno-oncology (12)
Indications (39)
Infectious disease (2742)
Inflammatory bowel disease (95)
Inflation Reduction Act (9)
Influenza (77)
Intellectual property (102)
Interviews (232)
IPO (10525)
IRA (45)
Job creations (1756)
Job search strategy (959)
Kidney cancer (8)
Labor market (34)
Layoffs (317)
Leadership (13)
Legal (7086)
Liver cancer (60)
Longevity (11)
Lung cancer (360)
Lymphoma (187)
Machine learning (19)
Management (32)
Manufacturing (360)
MASH (88)
Medical device (6026)
Medtech (6035)
Mergers & acquisitions (14217)
Metabolic disorders (812)
Multiple sclerosis (74)
NASH (20)
Neurodegenerative disease (114)
Neuropsychiatric disorders (33)
Neuroscience (1809)
NextGen: Class of 2025 (3663)
Non-profit (2781)
Now hiring (8)
Obesity (431)
Opinion (216)
Ovarian cancer (75)
Pain (80)
Pancreatic cancer (115)
Parkinson's disease (150)
Partnered (15)
Patents (235)
Patient recruitment (149)
Peanut (40)
People (25268)
Pharmaceutical (19)
Pharmacy benefit managers (14)
Phase I (14913)
Phase II (21462)
Phase III (17386)
Pipeline (1850)
Policy (220)
Postmarket research (1846)
Preclinical (6219)
Press Release (28)
Prostate cancer (129)
Psychedelics (36)
Radiopharmaceuticals (223)
Rare diseases (385)
Real estate (2592)
Recruiting (44)
Regulatory (16867)
Reports (24)
Research institute (1603)
Resumes & cover letters (197)
Rett syndrome (11)
RNA editing (6)
RSV (60)
Schizophrenia (92)
Series A (93)
Series B (71)
Service/supplier (4)
Sickle cell disease (43)
Special edition (8)
Spinal muscular atrophy (139)
Sponsored (22)
Startups (1899)
State (1)
Stomach cancer (12)
Supply chain (68)
Tariffs (57)
The Weekly (47)
Vaccines (895)
Venture capital (40)
Weight loss (298)
Women's health (24)
Worklife (10)
Date
Today (35)
Last 7 days (236)
Last 30 days (1282)
Last 365 days (20087)
2025 (14048)
2024 (22368)
2023 (25268)
2022 (33400)
2021 (35905)
2020 (34109)
2019 (27915)
2018 (21235)
2017 (20191)
2016 (18715)
2015 (21499)
2014 (15968)
2013 (12890)
2012 (13639)
2011 (14423)
2010 (13094)
Location
Africa (576)
Alabama (39)
Alaska (3)
Arizona (102)
Arkansas (5)
Asia (26467)
Australia (4741)
California (5187)
Canada (1621)
China (551)
Colorado (209)
Connecticut (232)
Delaware (164)
Europe (63473)
Florida (792)
Georgia (172)
Hawaii (3)
Idaho (30)
Illinois (387)
India (31)
Indiana (254)
Iowa (14)
Japan (198)
Kansas (70)
Kentucky (19)
Louisiana (12)
Maine (30)
Maryland (808)
Massachusetts (3680)
Michigan (133)
Minnesota (191)
Mississippi (1)
Missouri (61)
Montana (20)
Nebraska (10)
Nevada (60)
New Hampshire (22)
New Jersey (1582)
New Mexico (15)
New York (1504)
North Carolina (653)
North Dakota (5)
Northern California (2429)
Ohio (151)
Oklahoma (7)
Oregon (10)
Pennsylvania (1090)
Puerto Rico (8)
Rhode Island (16)
South America (800)
South Carolina (19)
South Dakota (1)
Southern California (1973)
Tennessee (65)
Texas (652)
United States (18627)
Utah (118)
Virginia (142)
Washington D.C. (42)
Washington State (397)
West Virginia (2)
Wisconsin (40)
405,852 Results for "itm isotopen technologien muenchen ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225
September 12, 2025
·
7 min read
Press Releases
ITM to Present at the Oppenheimer Annual Targeted Radiopharmaceutical Therapies in Oncology Summit
September 4, 2025
·
1 min read
Press Releases
ITM and Debiopharm Announce First Patient Imaged in New Study Arm of Phase 1/2 Trial Evaluating ITM-94 as Diagnostic Agent for Clear Cell Renal Cell Carcinoma (ccRCC)
June 23, 2025
·
6 min read
Press Releases
ITM to Present New Subgroup Analysis Data from the COMPETE Trial at ESMO 2025 and Host an Educational Event for Healthcare Professionals
August 19, 2025
·
3 min read
Press Releases
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177
May 20, 2025
·
3 min read
Press Releases
ITM and ILL Extend Collaboration on the Manufacturing and Supply of Medical Lutetium-177 Radioisotope
June 16, 2025
·
4 min read
Press Releases
ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225
April 24, 2025
·
4 min read
Press Releases
ITM to Provide COMPETE Trial Insights at SNMMI 2025 Annual Meeting in Oral Presentation and Satellite Symposium
June 13, 2025
·
3 min read
Press Releases
Barbara Weber, M.D., Elected to ITM Supervisory Board
April 9, 2025
·
3 min read
Press Releases
ITM Announces Updates to Commercial Leadership
March 14, 2025
·
4 min read
1 of 40,586
Next
